Jones Pharma Incorporated
Records under this name other than patents Jones Pharma Incorporated holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Jones Pharma Incorporated
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,714,006 | Methods of modifying the bioavailability of metaxalone Formerly held Term ended Term ended Jan 14, 2025 · USPTO record | Term ended | Term ended Jan 14, 2025 | USPTO record |
| US 7,005,416 | Dalfopristine/Quinupristine Combinations with Cefpirome Formerly held Term ended Term ended Aug 10, 2022 · High confidence | Term ended | Term ended Aug 10, 2022 | High confidence |
| US 6,555,581 | Levothyroxine compositions and methods Formerly held Term ended Term ended Feb 15, 2022 · USPTO record | Term ended | Term ended Feb 15, 2022 | USPTO record |
| US 6,407,128 | Method for increasing the bioavailability of metaxalone Formerly held Term ended Term ended Dec 3, 2021 · USPTO record | Term ended | Term ended Dec 3, 2021 | USPTO record |
| US 6,683,102 | Methods of using metaxalone in the treatment of musculoskeletal conditions Formerly held Term ended Term ended Dec 3, 2021 · USPTO record | Term ended | Term ended Dec 3, 2021 | USPTO record |
| US 6,187,746 | Pharmaceutical compositions based on dalfopristine and on quinupristine, and preparation thereof Formerly held Term ended Term ended Dec 15, 2018 · USPTO record | Term ended | Term ended Dec 15, 2018 | USPTO record |
| US 4,626,538 | [7-(3-Disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines Term ended Term ended no later than Dec 2, 2006 · Low confidence | Term ended | Term ended no later than Dec 2, 2006 | Low confidence |
| US 5,714,607 | Process improvement in the synthesis of N-3-(3-cyano-pyrazolo1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide Formerly held Term ended Term ended no later than Feb 3, 2018 · Low confidence | Term ended | Term ended no later than Feb 3, 2018 | Low confidence |
| US 5,994,338 | Stabilized pharmaceutical compositions, with quinupristine and dalfopristine base and their preparation Formerly held Term ended Term ended no later than Nov 30, 2019 · Low confidence | Term ended | Term ended no later than Nov 30, 2019 | Low confidence |